KVC Kardiovaskularne Centrum s.r.o.
- Address
- Prieloztek 1, Jahodniky, 036 01 Martin, Slovakia
KVC Kardiovaskularne Centrum s.r.o. - Cardiovascular Research Center
KVC Kardiovaskularne Centrum s.r.o. is a specialized cardiovascular research facility with extensive expertise in heart failure clinical trials. The center focuses on evaluating novel therapeutic approaches and interventions for patients with chronic heart failure, particularly those with complex comorbidities including impaired kidney function and iron deficiency.
- Advanced heart failure therapeutics and combination drug therapies including balcinrenone/dapagliflozin studies
- Heart failure with reduced ejection fraction (LVEF < 50%) and biomarker-driven treatment optimization
- Iron deficiency management in chronic heart failure patients using intravenous iron formulations
- Cardiovascular mortality and hospitalization reduction strategies in symptomatic heart failure populations
The center specializes in Phase III cardiovascular trials with complex endpoints, including assessment of cardiovascular death, heart failure events with and without hospitalization, and biomarker monitoring such as NT-proBNP. Their research portfolio demonstrates particular strength in evaluating patients with recent heart failure events and those requiring standard of care optimization including ACEI/ARB or sacubitril/valsartan therapy. The facility's expertise extends to managing iron-deficient heart failure populations and conducting proof-of-concept dose-finding studies for emerging cardiac therapeutics.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in KVC Kardiovaskularne Centrum s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Phase III Trial of Ferric Derisomaltose Versus No Intravenous Iron in Iron-Deficient Patients with Symptomatic Chronic Heart Failure | Pharmacosmos A/S | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azilsartan Medoxomil | 1 | Unknown | 2024-03-13 | 2024-03-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.